Exploring new in vivo models for cancer research

TAD is developing preclinical standardized in vivo model for cancer drugs evaluation.

Let’s advance
the science
together

We are actively exploring innovative murine models and proprietary statistical approaches to evaluate anticancer therapies. If your research group or company is seeking partners for collaborative R&D projects in oncology, we would be  delighted to connect— let’s advance the science together.